Union City, CA, United States of America

Xiao-Yan Zhao

USPTO Granted Patents = 5 

Average Co-Inventor Count = 6.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016-2022

Loading Chart...
5 patents (USPTO):

Title: **Xiao-Yan Zhao: Innovator in Monoclonal Antibody Research**

Introduction

Xiao-Yan Zhao, an accomplished inventor based in Union City, CA, has made significant contributions to the field of biotechnology, particularly in the development of humanized monoclonal antibodies. With a total of five patents to his name, Zhao's research focuses on innovative treatments utilizing these antibodies to inhibit activated protein C, presenting new avenues in medical therapies.

Latest Patents

Zhao's recent patents demonstrate his ingenuity and expertise. One of his key inventions is titled "Humanized monoclonal antibodies against activated protein C and uses thereof." This patent describes humanized antibodies that selectively bind to and inhibit activated protein C while avoiding interaction with unactivated protein C. The methods of treatment using these antibodies are extensively detailed. Another notable patent is "Epitope of optimized humanized monoclonal antibodies against activated protein C and uses thereof." This patent outlines optimized humanized antibodies that target specific epitopes outside the catalytic triad of the active site of activated protein C, further advancing treatment possibilities with these antibodies.

Career Highlights

Throughout his career, Xiao-Yan Zhao has worked with renowned organizations like Bayer Healthcare LLC and the Oklahoma Medical Research Foundation. His experiences in these companies have undoubtedly enriched his understanding and expertise in monoclonal antibody research.

Collaborations

Zhao has collaborated with notable coworkers in his innovative journey, including Ji-Yun Kim and Zhuozhi Wang. These partnerships have played a significant role in fostering creativity and advancing research in their field.

Conclusion

With a robust portfolio of patents and impactful collaborations, Xiao-Yan Zhao continues to push the boundaries of biomedical research. His work on humanized monoclonal antibodies holds promise for developing new therapeutic methods, making him a significant figure in the landscape of biotechnology innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…